Comparing Two Agents Used to Stop Bleeding During Tonsil Removal Surgery: Adrenaline Versus Hydrogen Peroxide
Efficacy of Hydrogen Peroxide Versus Adrenaline for Intraoperative Hemostasis During Tonsillectomy. A Quasi-Experimental Study
1 other identifier
interventional
64
1 country
1
Brief Summary
The goal of this quasi-experimental study is to compare the effectiveness of topical adrenaline and 3% hydrogen peroxide for controlling bleeding (hemostasis) during tonsil removal surgery in patients aged 5 to 18 years. The main questions it aims to answer are: 1. Which substance leads to faster bleeding control during surgery? 2. Which substance results in less total blood loss during surgery? Researchers compared the adrenaline group to the hydrogen peroxide group to see if one agent was more effective at managing bleeding than the other. Participants underwent a tonsillectomy where surgeons applied either gauze soaked in adrenaline (1:100,000 solution) or gauze soaked in 3% hydrogen peroxide to the tonsil area to stop bleeding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedFirst Submitted
Initial submission to the registry
June 23, 2026
CompletedFirst Posted
Study publicly available on registry
June 30, 2026
CompletedJune 30, 2026
June 1, 2026
1 year
June 23, 2026
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Severity of intraoperative blood loss during tonsillectomy as classified by combined gravimetric and volumetric assessment.
Total volume of blood lost during the surgical procedure, determined by the sum of blood volume calculated from the gravimetric method (pre- and post-operative weight of surgical gauze) and the volumetric method (suction canister volume). Results are categorized ordinally as: Mild (16-75 mL), Moderate (76-275 mL), or Severe (\>275 mL).
Measured during the intraoperative period, specifically from the time of hemostatic agent application until the completion of the tonsillectomy procedure.
Time to achieve intraoperative hemostasis during tonsillectomy as measured in minutes.
Time from the application of the hemostatic agent until the complete cessation of bleeding from the tonsillar fossa, as recorded by the surgical team. Time is recorded in categorical intervals: \<1 minute, 1-3 minutes, 3-5 minutes, and \>5 minutes.
Measured during the intraoperative period, specifically from the time of hemostatic agent application until the completion of the tonsillectomy procedure.
Study Arms (2)
Adrenaline Group
ACTIVE COMPARATORParticipants in this group receive topical application of adrenaline (1:100,000 solution) via gauze pieces immediately following the removal of tonsils during the surgical procedure to achieve hemostasis.
Hydrogen Peroxide Group
ACTIVE COMPARATORParticipants in this group receive topical application of 3% hydrogen peroxide via gauze pieces immediately following the removal of tonsils during the surgical procedure to achieve hemostasis.
Interventions
Topical application of 3% hydrogen peroxide solution.
Topical application of 1:100,000 adrenaline solution.
Eligibility Criteria
You may qualify if:
- Patients aged 5-18 years.
- Scheduled for elective tonsillectomy.
- Diagnosis of chronic or recurrent tonsillitis.
- Normal coagulation profile.
- Medically fit for general anesthesia.
- Provided informed consent (from participant, or parent/legal guardian for pediatric participants).
You may not qualify if:
- Patients with a coagulation or bleeding disorder.
- Patients taking blood-thinning medications (e.g., aspirin or other antiplatelet agents).
- Presence of an acute tonsillar infection at the time of surgery.
- Known reaction or allergy to adrenaline or hydrogen peroxide.
- Known or suspected tonsillar malignancy.
- Concurrent adenoid hypertrophy requiring adenoidectomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rawalpindi Teaching Hospital
Rawalpindi, Punjab Province, 46000, Pakistan
Related Publications (1)
Hsieh CY, Hsu CJ, Wu HP, Sun CH. Comparison Benefit between Hydrogen Peroxide and Adrenaline in Tonsillectomy: A Randomized Controlled Study. J Clin Med. 2022 May 11;11(10):2723. doi: 10.3390/jcm11102723.
PMID: 35628850BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The study utilized a single-blind design regarding the assessment of outcomes. Personnel responsible for evaluating intraoperative blood loss, including those weighing gauze and reading the suction canister volumes, were blinded to the group assignment of the participants. However, the operating surgeons and the surgical team were not masked, as they were required to know which hemostatic agent was being applied during the procedure to perform the intervention and record the time to hemostasis. Therefore, neither the participants, the care providers, nor the primary investigators were masked.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Efficacy of hydrogen peroxide Versus Adrenaline for Intraoperative Hemostasis During Tonsillectomy. A Quasi-Experimental Study
Study Record Dates
First Submitted
June 23, 2026
First Posted
June 30, 2026
Study Start
February 1, 2024
Primary Completion
January 31, 2025
Study Completion
January 31, 2025
Last Updated
June 30, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be made publicly available as part of a general data-sharing plan; however, the data that support the findings of this study are available from the corresponding author upon reasonable request.